Zai Lab (ZLAB) EBITDA (2020 - 2026)
Zai Lab (ZLAB) reported EBITDA of -$69.4 million for Q1 2026, down 23.22% on a YoY basis from -$90.4 million in Q1 2025, and little changed sequentially from -$69.4 million in Q4 2025.
Zai Lab (ZLAB) EBITDA (2020 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 7 years of EBITDA data on file, last reported at -$69.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA fell 23.22% year-over-year to -$69.4 million; the trailing twelve-month figure through Mar 2026 stood at -$242.5 million (up 9.55% YoY), and the FY2025 full-year result was -$229.4 million, up 18.67% from the prior year.
- EBITDA was little changed at -$69.4 million in Q1 2026, from -$69.4 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$48.8 million in Q3 2025 to a low of -$128.6 million in Q3 2022.
- A 5-year average of -$79.5 million and a median of -$70.3 million in 2024 frame the typical range for EBITDA.
- Peak annual rise in EBITDA reached 64.88% in 2022, while the deepest fall reached 54.54% in 2022.
- Tracing ZLAB's EBITDA over 5 years: stood at -$97.3 million in 2022, then decreased by 27.43% to -$124.0 million in 2023, then jumped by 45.24% to -$67.9 million in 2024, then fell by 2.23% to -$69.4 million in 2025, then advanced by 0.03% to -$69.4 million in 2026.
- Business Quant data shows ZLAB's EBITDA at -$69.4 million in Q1 2026, -$69.4 million in Q4 2025, and -$48.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | -69.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.39 Mn |
| Dec 31, 2025 | -69.41 Mn |
| Sep 30, 2025 | -48.82 Mn |
| Jun 30, 2025 | -54.90 Mn |
| Mar 31, 2025 | -56.31 Mn |
| Dec 31, 2024 | -67.89 Mn |
| Sep 30, 2024 | -67.85 Mn |
| Jun 30, 2024 | -76.06 Mn |
| Mar 31, 2024 | -70.31 Mn |
| Dec 31, 2023 | -123.98 Mn |
| Sep 30, 2023 | -83.57 Mn |
| Jun 30, 2023 | -89.50 Mn |
| Mar 31, 2023 | -69.52 Mn |
| Dec 31, 2022 | -97.29 Mn |
| Sep 30, 2022 | -128.58 Mn |
| Jun 30, 2022 | -98.72 Mn |
| Mar 31, 2022 | -79.76 Mn |
| Dec 31, 2021 | -219.20 Mn |
| Sep 30, 2021 | -83.21 Mn |
| Jun 30, 2021 | -170.57 Mn |